Epidemiology

You have full text access to this OnlineOpen article

Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer

  1. Geoffrey C. Kabat1,†,*,
  2. Mimi Kim1,
  3. Bette J. Caan2,
  4. Rowan T. Chlebowski3,
  5. Marc J. Gunter1,
  6. Gloria Y.F. Ho1,
  7. Beatriz L. Rodriguez4,
  8. James M. Shikany5,
  9. Howard D. Strickler1,
  10. Mara Z. Vitolins6,
  11. Thomas E. Rohan1

Article first published online: 2 JUN 2009

DOI: 10.1002/ijc.24609

Issue

International Journal of Cancer

International Journal of Cancer

Volume 125, Issue 11, pages 2704–2710, 1 December 2009

Additional Information

How to Cite

Kabat, G. C., Kim, M., Caan, B. J., Chlebowski, R. T., Gunter, M. J., Ho, G. Y.F., Rodriguez, B. L., Shikany, J. M., Strickler, H. D., Vitolins, M. Z. and Rohan, T. E. (2009), Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int. J. Cancer, 125: 2704–2710. doi: 10.1002/ijc.24609

Author Information

  1. 1

    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY

  2. 2

    Division of Research, Kaiser Permanente of Northern California, Oakland, CA

  3. 3

    Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA

  4. 4

    Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI

  5. 5

    Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL

  6. 6

    Department of Epidemiology and Prevention, School of Medicine, Wake Forest University, Winston Salem, NC

  1. †

    Fax: +718-430-8653.

*Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA

Publication History

  1. Issue published online: 24 SEP 2009
  2. Article first published online: 2 JUN 2009
  3. Accepted manuscript online: 2 JUN 2009 12:00AM EST
  4. Manuscript Accepted: 19 MAY 2009
  5. Manuscript Received: 2 APR 2009

Funded by

  • Institutional funds

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (103K)

References

  • 1
    Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996; 7: 605–25.
  • 2
    Vona-Davis L,Howard-McNatt M,Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 2007; 8: 395–408.
  • 3
    Chappell J,Leitner JW,Solomon S,Golovchenko I,Goalstone ML,Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. J Biol Chem 2001; 276: 38023–8.
  • 4
    Ish-Shalom D,Christoffersen CT,Vorwerk P,Sacerdoti-Sierra N,Shymko RM,Naor D,De Meyts P. Mitogenic properties of insulin and insulin anologues mediated by the insulin receptor. Diabetologia 1997; 40 Suppl 2: S25–S31.
  • 5
    Shafie SM,Hilf R. Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a) anthracene-induced mammary tumors in rats. Cancer Res 1981; 41: 826–9.
  • 6
    Shafie SM,Grantham FH. Role of hormones in the growth and regression of human breast cancer cell (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 1981; 67: 51–6.
  • 7
    Marshall S,Bacote V,Traxinger RR. Discovery of a metabolic pathway mediating glucose induced desentitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706–12.
  • 8
    Warburg O. On the origin of cancer cells. Science 1956; 123: 309–14.
  • 9
    Dang CV,Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24: 68–72.
  • 10
    Manjer J,Kaaks R,Riboli E,Berglund G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project. Eur J Cancer Prev 2001; 10: 33–42.
  • 11
    Mink PJ,Shahar E,Rosamond WD,Alberg AJ,Folsom AR. Serum insulin and glucose levels and breast cancer incidence: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2002; 156: 349–52.
  • 12
    Muti P,Quattrin T,Grant BJ,Krogh V,Micheli A,Schünemann HJ,Ram M,Freudenheim JL,Sieri S,Trevisan M,Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1361–8.
  • 13
    Jee SH,Ohrr H,Sull JW,Yun JE,Ji M,Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194–202.
  • 14
    Rapp K,Schroeder J,Klenk J,Ulmer H,Concin H,Diem G,Oberaigner W,Weiland SK. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945–52.
  • 15
    Stattin P,Björ O,Ferrari P,Lukanova A,Lenner P,Lindahl B,Hallmans G,Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007; 30: 561–7.
  • 16
    Jernström H,Barrett-Connor E. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer in the Rancho Bernardo Study. J Womens Health Gend Based Med 1999; 8: 1265–72.
  • 17
    Kaaks R,Lundin E,Rinaldi S,Manjer J,Biessy C,Söderberg S,Lenner P,Janzon L,Riboli E,Berglund G,Hallmans G. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden. Cancer Causes Control 2002; 13: 307–16.
  • 18
    Gunter MJ,Hoover DR,Yu H,Wassertheil-Smoller S,Rohan TE,Manson JE,Li J,Ho GY,Xue X,Anderson GL,Kaplan RC,Harris TG, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101: 48–60.
  • 19
    The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998; 19: 61–109.
  • 20
    Chlebowski TR,Chen Z,Anderson GL,Rohan T,Aragaki A,Lane D,Dolan NC,Paskett ED,McTiernan A,Hubbell FA,Adams-Campbell LL,Prentice R. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005; 97: 439–48.
  • 21
    Howard BV,Adams-Campbell L,Allen C,Black H,Passaro M,Rodabough RJ,Rodriguez BL,Safford M,Stevens VJ,Wagenknecht LE. Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes 2004; 28: 1039–47.
  • 22
    Bergmeyer HU,Bernt E,Schmidt F,Stork H. Determination of hexokinase and glucose-6-phosphate dehydrogenase. In: BergmeyerHU, ed. Methods of enzymatic analysis,2nd Engl. edn. New York, NY: Academic Press, 1974, 1196–1201.
  • 23
    Peterson JI,Young DS. Evaluation of the hexokinase-glucose-6-phosphate dehydrogenase method of determination of glucose in urine.Anal Biochem 1968; 23: 301–316.
  • 24
    Tietz NW. Fundamentals of Clinical Chemistry, 3rd edn. Philadelphia, PA: WB Saunders Co, 1987. 544 p.
  • 25
    Matthews DR,Hosker JP,Rudenski AS,Naylor BA,Treacher DF,Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 287: 412–19.
  • 26
    Goodwin PJ,Ennis M,Bahl M,Fantus IG,Pritchard KI,Trudeau ME,Koo J,Hood N. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 2008; 114: 517–25.
  • 27
    Kanaya AM,Herrington D,Vittinghoff E,Lin F,Grady D,Bittner V,Cauley JA,Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Int Med 2003; 138: 1–9.
  • 28
    Gail M. Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 1981; 37: 67–78.
  • 29
    Verheus M,Peeters PH,Rinaldi S,Dossus L,Biessy C,Olsen A,Tjønneland A,Overvad K,Jeppesen M,Clavel-Chapelon F,Téhard B,Nagel G, et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006; 119: 659–67.
  • 30
    Ikeda Y,Suehiro T,Nakamura T,Kumon Y,Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001; 48: 81–6.
  • 31
    Prentice R. Covariate measurement errors and parameter estimation in a failure time regression model. Biometrika 1982; 69: 331–42.
  • 32
    Milazzo G,Giorgino F,Damante F,Sung C,Stampfer MR,Vigneri R,Goldfine ID,Belfiore A. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992; 52: 3924–30.
  • 33
    Mawson A,Lai A,Carroll JS,Sergio CM,Mitchell CJ,Sarcevic B. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 2005; 229: 161–73.
  • 34
    Katzel LI,Bleeker ER,Colman EG,Rogus EM,Sorkin JD,Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men: a randomized controlled trial. JAMA 1995; 274: 1915–21.
  • 35
    Chlebowski RT,Pettinger M,Stefanick ML,Howard BV,Mossavar-Rahmani Y,McTiernan A. Insulin, physical activity, and caloric intake in postmenopausal women: breast cancer implications. J Clin Oncol 2004; 22: 4507–13.
View Full Article (HTML) Get PDF (103K)